Diaceutics (FRA:7DC) Tariff Resilience Score: 0/10 (As of Jul. 06, 2026)


FRA:7DC Diaceutics PLC FRA:7DC
91 GF Score
Price €1.64
GF Value €2.14
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Diaceutics Tariff Resilience Score?

Diaceutics has the Tariff Resilience Score of 0, which implies that the company might have .

Diaceutics has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Diaceutics might have .

Diaceutics  (FRA:7DC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Diaceutics Tariff Resilience Score Related Terms

FRA:7DC
91GF Score
Diaceutics PLC FRA:7DC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diaceutics (FRA:7DC) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of €1.64 is trading 23.4% below its estimated GF Value™ of €2.14. GuruFocus considers Diaceutics to be Modestly Undervalued.

Key valuation signals for FRA:7DC:

  • Tariff Resilience Score: 0
  • GF Value™: €2.14 vs. price of €1.64 (23.4% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the FRA:7DC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DIUXF:USADXRX:UK
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
91GF Score

Get the complete analysis for FRA:7DC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.64
Price
€2.14
GF Value